McKinley Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$15.1M Sell
16,721
-1,933
-10% -$1.55M 2.65% 8
2024
Q1
$14.5M Buy
18,654
+1,766
+10% +$1.26M 1.74% 9
2023
Q4
$9.84M Buy
16,888
+9,213
+120% +$5.38M 1.26% 16
2023
Q3
$4.12M Buy
7,675
+2,602
+51% +$1.34M 0.58% 62
2023
Q2
$2.38M Sell
5,073
-46
-0.9% -$19.3K 0.32% 91
2023
Q1
$1.76M Sell
5,119
-182
-3% -$61.4K 0.23% 106
2022
Q4
$1.94M Buy
5,301
+991
+23% +$351K 0.26% 100
2022
Q3
$1.39M Buy
+4,310
New +$1.37M 0.19% 115
2016
Q1
Sell
-193,173
Closed -$16.3M 374
2015
Q4
$16.3M Buy
+193,173
New +$16M 0.75% 38
2015
Q1
Sell
-6,081
Closed -$420K 336
2014
Q4
$420K Sell
6,081
-64
-1% -$4.32K 0.02% 265
2014
Q3
$398K Buy
+6,145
New +$389K 0.02% 263

Other funds holding LLY

McKinley Capital Management's LLY Position: Q2 2024 in Review

McKinley Capital Management reduced its Eli Lilly (LLY) stake by 10% in Q2 2024, selling an estimated $1.55M and leaving 16,721 shares worth $15.1M. The position accounts for 2.65% of the portfolio, ranked #8.

McKinley Capital Management first reported a position in LLY in Q3 2014 and has held it in 11 quarters since. The position peaked at $16.3M in Q4 2015. 3,565 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • McKinley Capital Management held 16,721 shares of Eli Lilly worth $15.1M as of Q2 2024.
  • McKinley Capital Management sold 1,933 Eli Lilly shares in Q2 2024, an estimated $1.55M.
  • Eli Lilly made up 2.65% of McKinley Capital Management's portfolio in Q2 2024, its #8 holding.
  • McKinley Capital Management first reported a position in Eli Lilly in Q3 2014 and has held it in 11 quarters since.
  • McKinley Capital Management's Eli Lilly position peaked at $16.3M in Q4 2015.
  • 3,565 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on McKinley Capital Management's 13F filing for Q2 2024, filed 12 Aug 2024.